Title:
AMIDE COMPOUND AND USE THEREOF IN PREPARATION OF INHIBITOR OF SIGMA2 AND 5HT2A
Document Type and Number:
WIPO Patent Application WO/2024/067302
Kind Code:
A1
Abstract:
The present invention provides an amide compound, which has inhibitory activity against the Sigma2 receptor and 5HT2A receptor and can be used as a dual-target inhibitor of Sigma2 and 5HT2A for the treatment of a related disease mediated by Sigma2 receptor activity, the treatment of a related disease mediated by 5HT2A receptor activity, and the treatment of a related disease mediated jointly by Sigma2 receptor activity and 5HT2A receptor activity, such as negative symptoms of schizophrenia.
Inventors:
XING HONGTAO (CN)
Application Number:
PCT/CN2023/120114
Publication Date:
April 04, 2024
Filing Date:
September 20, 2023
Export Citation:
Assignee:
HAN YUAN MEDI PHARMA CO LTD (CN)
International Classes:
C07D211/26; A61K31/445; A61K31/4545; A61P25/00; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; C07D211/34; C07D401/12
Attorney, Agent or Firm:
BEIJING YUNJIN IP LAW FIRM et al. (CN)
Download PDF: